在患有类风湿性关节炎的患者中模仿血管炎的原发性皮肤加密球菌病
Fatmanur Pepe1, Derya Seyman1, Sacide Nur Aksoy1
1Health Sciences University, Antalya Education and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Antalya, Türkiye.
The new microbiologica
|December 23, 2025
概括
本病例报告详细介绍了一例罕见的原发性皮肤加密球菌病例,该病例发生在患有类风湿性关节炎的免疫功能低下患者身上. 早期诊断和治疗对于管理非艾滋病毒患者这种机会性真菌感染至关重要.
科学领域:
- 菌类学 菌类学是指菌类学.
- 皮肤病学 皮肤病学
- 免疫功能受损的宿主感染
背景情况:
- 这是Cryptococcus spp. 是已知的机会性病原体,主要在感染艾滋病毒的个体中.
- 最近的趋势表明,在其他免疫功能低下的患者群体中,加密球菌病的发病率正在增加.
- 长期使用皮质类固醇治疗类风湿性关节炎 (RA) 可能使患者易患机会性感染.
研究的目的:
- 报告一种罕见的原发性皮肤加密球菌病例.
- 强调在没有艾滋病毒的免疫受损患者的诊断挑战和临床表现.
- 强调在不愈合的皮肤病变中考虑真菌感染的重要性.
主要方法:
- 一个73岁的男性患有类风湿性关节炎,长期服用皮质类固醇的临床病例介绍.
- 皮肤活检的组织病理学检查,使用周期性酸-Schiff (PAS) 和粘胺染色.
- 血清学加密球菌抗原测试.
主要成果:
- 这位患者出现了痛苦的,无法愈合的性瘤病变和出血球块.
- 皮肤活检揭示了与Cryptococcus一致的酵母形式,通过PAS和粘胺污染物证实了这一点.
- 阳性血清密码球菌抗原测试.
- 随着可纳治疗,临床症状的部分改善.
结论:
- 初级皮肤加密球菌病是一种罕见但严重的机会性感染,发生在免疫功能低下的患者身上,包括那些接受皮质类固醇治疗的RA患者.
- 皮肤真菌感染应在免疫受损个体的非愈合性皮肤病变的差异诊断中考虑.
- 尽管接受了治疗,但患者因其潜在的全身性疾病的并发症而死亡,这凸显了这种人群中机会性感染的严重性.
相关概念视频
Endocarditis II: Clinical Features of Infective Endocarditis
364
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
364
Rheumatic Heart Disease I: Introduction
404
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
404
Skin Diseases and Disorders
5.1K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.1K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
439
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
439
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
405
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
405
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
454
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
454


